2022 Districts IV & VII Annual District Meeting

Together in Wellness: Reflect, Recharge, Reengage

Asheville, North Carolina | Sep 30- Oct 2, 2022

Product Theaters

ZULRESSO (brexanalone): Addressing Perceptions of Postpartum Depression (PPD)

Sponsored by Sage Therapeutics

Friday, September 30, 2022
Noon–1 p.m.

This session aims to address some possible perceptions of PPD treatment and the role of ZULRESSO® (brexanolone) injection, for intravenous use, as the first FDA-approved pharmacologic therapy for postpartum depression in patients 15 years and older.

Speaker: David Silver, MD, MBA, FACOG

David Silver, MD, specializes in psychiatry and is certified in obstetrics and gynecology and neurology by the American Board of Obstetrics and Gynecology. He practices at UPMC Women's Behavioral Health Specialists and is affiliated with UPMC Community Osteopathic, UPMC West Shore, and UPMC Harrisburg. He completed his fellowship program at Roswell Park Cancer Institute, residencies at University of Pennsylvania School of Medicine, Union Memorial Hospital at Baltimore, and medical degree at Sidney Kimmel Medical College—Thomas Jefferson University.

The Significance of Diagnostic Testing in Women’s Health: Prevention, Early Detection and Management

Sponsored by Hologic, Inc.

Friday, September 30, 2022
Noon–1 p.m.

Please join us as we discuss real-world data reflective of current clinical practices in the US for Cervical Cancer Screening and Mycoplasma genitalium. We will also address ways in which we can improve patient care through established screening guidelines.

Speaker: Michael Randell, MD, FACOG

Dr. Michael Randell is an award-winning board-certified obstetrician–gynecologist in private practice in Atlanta, Georgia, and is on the Medical Staff at Emory Saint Joseph's Hospital in the Department of Gynecology. He received his medical degree with research distinction from the University of Miami School of Medicine and completed his internship and residency at the University of Miami/Jackson Memorial Medical Center. His research interests have led to many notable presentations at various scientific meetings.

Updates and Case Reviews in Pelvic Mass Risk Assessment and Ovarian Cancer

Sponsored by Fujirebio

Saturday, October 1, 2022
12:45–1:45 p.m.

Join us during the 2022 ACOG Districts IV and VII Annual District Meeting for an educational lunch symposium on the use of biomarkers to guide referrals of an adnexal mass and to assist with the management of patients with ovarian cancer.

Learning Objectives:

  • Provide an update on the latest guidance on assessing adnexal masses
  • Discuss diagnostic biomarkers and algorithms, including CA125, HE4, and ROMA
  • Review adnexal mass and ovarian cancer cases with audience participation

Speaker: Richard G. Moore, MD, FACS, FACOG

Dr. Moore is a professor and Chief of the Gynecologic Oncology Division at the University of Rochester Medical Center. He is also a Director and Targeted Therapeutics Laboratory Chair of Gynecology Service Line at the Wilmot Cancer Institute.

Real-World Experience Using the BD Onclarity™ HPV Assay with Extended Genotyping

Sponsored by BD Life Sciences

Saturday, October 1, 2022
12:45–1:45 p.m.

This session will include real-world data from using the BD Onclarity™ HPV assay with extended genotyping at a pathology practice. There will also be a presentation with detailed information about the BD Onclarity™ assay, including indications for use, design, and supporting clinical evidence.

Speakers: Phillip D. Stephenson, DO, and Molly Broache, BSN, MSN, WHNP

Dr. Stephenson is cytopathology director at Associates of Pathology in Ogden, Utah. Molly Broache is associate director of U.S. medical affairs for Becton, Dickinson and Company.